Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies

IntroductionMigraine is a debilitating neurological disorder, with a wide range of symptoms and disease burden, underscoring the heterogeneity of patients’ disease characteristics and treatment needs. To characterize the profile of migraine patients in the US who may be eligible for preventive treat...

Full description

Bibliographic Details

Published in:	Frontiers in Neurology
Main Authors:	Ani C. Khodavirdi, Jasjit K. Multani, Sam S. Oh, Fiston Vuvu, Mark E. Bensink, Karen M. Stockl, Kevin Hawkins, Chia-Chun Chiang, A. Laine Green, Stewart J. Tepper
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	chronic migraine anti-calcitonin gene-related peptide treatment patterns non-chronic migraine monthly headache days
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1433423/full